Benjamin Paluch

Stock Analyst at Roth MKM

(0.94)

# 3,867

Out of 4,818 analysts

3

Total ratings

33.33%

Success rate

-7.89%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$21.47	+202.82%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$9.08	+87.22%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$3.10	+222.58%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $21.47

Upside: +202.82%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $9.08

Upside: +87.22%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $3.10

Upside: +222.58%